Navigation Links
Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
Date:8/19/2007

CHAPEL HILL, N.C., Aug. 10 /PRNewswire/ -- More than 33% of pharmaceutical and biotech companies are able to identify clinical investigators 50% faster than their industry peers. These companies are able to significantly reduce clinical trial costs while improving quality by employing on-going relationship management tactics and centralized databases, according to research probing clinical trial excellence by pharmaceutical consulting firm Best Practices, LLC.

Best Practices LLC's Clinical Trial Excellence Series is a critical tool for executives searching for tactics to optimize their clinical trials. Developed from extensive surveys and interviews with executives at leading pharmaceutical, biotech and clinical research organizations, this series provides a detailed guide to ensuring faster and better clinical trial recruitment and retention.

Profiled in a complimentary download summary at http://www3.best-in-class.com/rr839.htm, research details findings such as:

-- The most valuable services for more than 70% of investigators are

patient recruitment funding and high-quality investigator meetings.

This is in sharp contrast to pharmaceutical and biotech companies

that said investigators most value study coordinator training and

phone support.

-- An adequate and reasonable budget is the most critical factor for

85% of interviewed clinical investigators.

-- The best companies develop and grow customer-relationship databases

with detailed investigator and site information to help jumpstart

study recruitment or entry into a new therapeutic area.

Benchmarked companies, including 3M Pharmaceuticals, Abbott Laboratories, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer and Roche, have succeeded in:

-- Winning 50-80% higher investigator performance ratings than most

companies.

-- Commencing investigator selection and recruitment 3-6 months

earlier than average companies.

-- Identifying and recruiting investigators 2-4 times faster than

competitors in the benchmark class.

Download the complimentary excerpt of the Clinical Trial Excellence Series at http://www3.best-in-class.com/rr839.htm or contact our Solution Specialists at (919) 403-0251 or bestpractices@best-in-class.com for more information.

ABOUT BEST PRACTICES, LLC

Best Practices, LLC, conducts work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies. Best Practices, LLC has been a leader in pharmaceutical research and consulting for nearly 15 years; our clients include 43 out of the top 50 pharmaceutical companies.


'/>"/>
SOURCE Best Practices, LLC

Copyright©2007 PR Newswire.

Related medicine technology :

1. Genetic Analysis Systems Enter the Clinical Mainstream
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Large Geographic Differences in EpiPen Prescriptions in the U.S., From the Journal of Allergy and Clinical Immunology
4. Sygnis Pharma AG announces date for presentation of clinical results
5. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Clinical Data Suggest Decreased Bleeding Risk in People With Severe Hemophilia A While Maintaining Factor VIII Levels Above One Percent
7. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
8. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
9. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
10. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
11. Protox Announces Positive Clinical Data from Prostate Cancer Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... PRO-DEX, INC. (NasdaqCM: PDEX) today announced financial results for its ... also filed its Quarterly Report on Form 10-Q for the ... Exchange Commission today. --> --> ... --> Net sales for the three months ... $5.4 million from $2.8 million for the three months ended ...
(Date:2/11/2016)... 11, 2016  Walgreens has committed to provide drug ... Washington, D.C. as part of a ... commended by shareholder advocacy organization As You Sow. ... "Many people hold on to unneeded drugs because they lack ... consequences." --> Conrad MacKerron , Senior Vice ...
(Date:2/11/2016)... Feb. 11, 2016 Potrero Medical, Inc., the developer ... announce the appointment of George M. Rapier, III , ... Antonio, TX , WellMed is one of the nation,s ... and HMO members in Texas and ... out of his own internal medicine practice, he has been ...
Breaking Medicine Technology:
(Date:2/12/2016)... ... , ... AssureVest Insurance Group, a locally owned insurance firm with offices serving ... funds earmarked to purchase computers and software for Mrs. Harrison’s 2nd and 3rd grade ... a low-income area and has more than 60 2nd and 3rd graders with learning ...
(Date:2/12/2016)... (PRWEB) , ... February 12, 2016 , ... Erlanger Agency ... the greater Columbus, OH area. The latest campaign focuses on the fight against breast ... Donations are now being accepted here . , Carmen is a loving single ...
(Date:2/12/2016)... ... 2016 , ... Miami Dental Specialists is excited to bring patients the choice ... in January, Miami Dental Specialists will offer the non-metal implants as a safe, holistic ... be chosen by the dental implant manufacturer, Straumann, to bring this cutting-edge technology to ...
(Date:2/12/2016)... ... February 12, 2016 , ... Mediaplanet today ... , The print component of “Revolutionizing Cancer Care” is distributed within the February ... and Seattle, with a circulation of approximately 250,000 copies and an estimated readership ...
(Date:2/12/2016)... ... February 12, 2016 , ... Homeowners now ... design possibilities. CertainTeed, North America’s leading brand of building products, has improved upon ... showcased in the mobile version of the ColorView® Exterior Style and Color Selector. ...
Breaking Medicine News(10 mins):